Hyoscyamine is an investigational drug.
There have been 3 clinical trials for Hyoscyamine.
The most recent clinical trial was a Phase 1 trial, which was initiated on November 12th 2018.
The most common disease conditions in clinical trials are Dyspepsia, Digestive System Diseases, and Abdominal Pain. The leading clinical trial sponsors are Boston Children’s Hospital, University of Kansas Medical Center, and FKD Therapies Oy of Finland.